Ronnie Coleman Signature Series (RCSS) has formally established an exclusive strategic agreement with Bright Lifecare (HealthKart), one of India's top health and wellness organizations, marking a significant milestone for the country's fitness and
Fortis Healthcare is prioritizing obesity treatment and developing obesity clinics throughout India to address increasing demand for weight-loss drugs and therapies.The initiative is taking place as India is set to be the world's second-largest...
Alkem Laboratories announced the launch of Pertuza injection 420mg/14mL, a pertuzumab biosimilar that has been developed in India and can be used in HER2-positive breast cancer. With this achievement, Alkem aims to provide better access to...
Akums Drugs & Pharmaceuticals highlights lacosamide, a well-established antiepileptic drug (AED), as a versatile and effective option for patients with epilepsy across age groups and clinical settings. Recognized for its broad clinical applicability,
The opening of a new glass tubing factory in Telangana by Corning Incorporated and SGD Pharma would increase pharmaceutical production in the area. The new facility will help address capacity issues and quality requirements in primary glass packaging
Pfizer Inc. revealed that it is acquiring Metsera, Inc. for $4.9 billion in cash, further enhancing its pipeline in obesity and cardio-metabolic diseases. The definitive agreement was approved unanimously by both companies' boards and is a...
According to a notification, India has restricted the import of a chemical used in the pharmaceutical business until September 30 of next year
Piramal Pharma Solutions (PPS), a global leader in contract development and manufacturing (CDMO) and a division of Piramal Pharma Ltd., has announced the installation of a cutting-edge Korsch XM-12 bilayer tablet press at its Morpeth facility in the
Metropolis Healthcare, a diagnostics company with its headquarters in Mumbai, stated on Thursday that it has paid Rs 17 crore to acquire Ambika Pathology Laboratory, located in Kolhapur.A deferred component of Rs 1.7 crore is included in the consider
Lupin, a pharmaceutical company based in Mumbai, announced on Wednesday that the US Food and Drug Administration (US FDA) had approved a generic version of Lenalidomide capsules in many strengths, including 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25
.jpg)
, CDSCO.jpg)